Rhaman M, Islam M, Akash S, Mim M, Alam M, Nepovimova E
Front Cell Dev Biol. 2022; 10:989471.
PMID: 36120565
PMC: 9478743.
DOI: 10.3389/fcell.2022.989471.
Lv W, Liu Y, Li S, Lv L, Lu H, Xin H
J Nanobiotechnology. 2022; 20(1):248.
PMID: 35641956
PMC: 9153106.
DOI: 10.1186/s12951-022-01450-5.
Fernandes D, Appak-Baskoy S, Berndl E, Kolios M
RSC Adv. 2022; 11(9):4906-4920.
PMID: 35424456
PMC: 8694477.
DOI: 10.1039/d0ra08009h.
Suresh D, Suresh A, Kannan R
Bioact Mater. 2022; 18:321-336.
PMID: 35415301
PMC: 8965973.
DOI: 10.1016/j.bioactmat.2022.02.035.
Kaynak A, Davis H, Vallabhapurapu S, Pak K, Gray B, Qi X
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832975
PMC: 8619974.
DOI: 10.3390/ph14111193.
MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications.
Ahmed N, Gandhi D, Melhem E, Frenkel V
Front Neurol. 2021; 12:669449.
PMID: 34220679
PMC: 8248790.
DOI: 10.3389/fneur.2021.669449.
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis H, Vallabhapurapu S, Chu Z, Wyder M, Greis K, Fannin V
Cells. 2020; 9(9).
PMID: 32854321
PMC: 7565346.
DOI: 10.3390/cells9091960.
Recent advances in nanotherapeutic strategies for spinal cord injury repair.
Song Y, Agrawal N, Griffin J, Schmidt C
Adv Drug Deliv Rev. 2018; 148:38-59.
PMID: 30582938
PMC: 6959132.
DOI: 10.1016/j.addr.2018.12.011.
Vascular targeted nanotherapeutic approach for obesity treatment.
Sibuyi N, Meyer M, Onani M, Skepu A, Madiehe A
Int J Nanomedicine. 2018; 13:7915-7929.
PMID: 30538468
PMC: 6260142.
DOI: 10.2147/IJN.S173424.
Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
Nair K, Ramaiyan V, Sukumaran S
Inflammopharmacology. 2018; 26(3):675-684.
PMID: 29582240
DOI: 10.1007/s10787-018-0468-y.
Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
Bouras A, Kaluzova M, Hadjipanayis C
J Neurooncol. 2015; 124(1):13-22.
PMID: 25981803
PMC: 4498963.
DOI: 10.1007/s11060-015-1807-0.
Nanoparticles for brain drug delivery.
Masserini M
ISRN Biochem. 2015; 2013:238428.
PMID: 25937958
PMC: 4392984.
DOI: 10.1155/2013/238428.
"Extremely minimally invasive": recent advances in nanotechnology research and future applications in neurosurgery.
Mattei T, Rehman A
Neurosurg Rev. 2014; 38(1):27-37.
PMID: 25173621
DOI: 10.1007/s10143-014-0566-2.
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.
Phillips W, Bao A, Brenner A, Goins B
Adv Drug Deliv Rev. 2014; 76:39-59.
PMID: 25016083
PMC: 4414016.
DOI: 10.1016/j.addr.2014.07.001.
Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Zaim Wadghiri Y, Li J, Wang J, Hoang D, Sun Y, Xu H
PLoS One. 2013; 8(2):e57097.
PMID: 23468919
PMC: 3584149.
DOI: 10.1371/journal.pone.0057097.
Therapeutic anti-methamphetamine antibody fragment-nanoparticle conjugates: synthesis and in vitro characterization.
Nanaware-Kharade N, Gonzalez 3rd G, Lay Jr J, Hendrickson H, Peterson E
Bioconjug Chem. 2012; 23(9):1864-72.
PMID: 22873701
PMC: 3463141.
DOI: 10.1021/bc300204n.
Nanotechnology applications for glioblastoma.
Nduom E, Bouras A, Kaluzova M, Hadjipanayis C
Neurosurg Clin N Am. 2012; 23(3):439-49.
PMID: 22748656
PMC: 3473084.
DOI: 10.1016/j.nec.2012.04.006.
New clathrin-based nanoplatforms for magnetic resonance imaging.
Vitaliano G, Vitaliano F, Rios J, Renshaw P, Teicher M
PLoS One. 2012; 7(5):e35821.
PMID: 22563470
PMC: 3341379.
DOI: 10.1371/journal.pone.0035821.
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.
Wankhede M, Bouras A, Kaluzova M, Hadjipanayis C
Expert Rev Clin Pharmacol. 2012; 5(2):173-86.
PMID: 22390560
PMC: 3461264.
DOI: 10.1586/ecp.12.1.
Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models.
Zhao Q, Wang L, Cheng R, Mao L, Arnold R, Howerth E
Theranostics. 2012; 2:113-21.
PMID: 22287991
PMC: 3267386.
DOI: 10.7150/thno.3854.